Chang LC, Hu HW, Hsieh MS, Wu SG, et al. Brief Report: The Effectiveness of Osimertinib in Advanced Nonsmall Cell Lung Cancer Harboring Various EGFR Exon 19 Mutation Variants. Clin Lung Cancer 2025 Mar 21:S1525-7304(25)00054.
PMID: 40221329